Rosetta Given Extensions to Meet Nasdaq Listing Requirements | GenomeWeb

Rosetta Genomics this week announced that it has received notice from the Nasdaq that it has been given an extension to regain compliance with the exchange's $2.5 million minimum stockholders' equity requirement for continued listing.

Under the terms of the extension, Rosetta must regain compliance by the quarter ended June 30. The company must meet certain milestones toward regaining compliance by Feb. 28 and April 29, as well.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."